These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 7983392
41. Cyclosporin A is not very effective in erythema nodosum leprosum (ENL). van Gompel A, van den Enden E, van den Ende J. Trop Geogr Med; 1994; 46(5):331. PubMed ID: 7710538 [No Abstract] [Full Text] [Related]
42. Chronic recurrent ENL, steroid dependent: long-term treatment with high dose clofazimine. Schreuder PA, Naafs B. Lepr Rev; 2003 Dec; 74(4):386-9. PubMed ID: 14750585 [No Abstract] [Full Text] [Related]
43. Epidemiological characteristics of leprosy reactions: 15 years experience from north India. Kumar B, Dogra S, Kaur I. Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):125-33. PubMed ID: 15301592 [Abstract] [Full Text] [Related]
44. Severe form of type 2 reaction in patients of Hansen's disease after withdrawal of thalidomide: case reports. Rattan R, Shanker V, Tegta GR, Verma GK. Indian J Lepr; 2009 Jun; 81(4):199-203. PubMed ID: 20704076 [Abstract] [Full Text] [Related]
45. A phase 2 open trial of pentoxifylline for the treatment of leprosy reactions. Dawlah ZM, Cabrera A, Ahern K, Levis WR. Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):38-43. PubMed ID: 12120041 [No Abstract] [Full Text] [Related]
46. Increased level of urinary nitric oxide metabolites in leprosy patients during type 2 reactions and decreased after antireactional therapy. Mohanty KK, Gupta M, Girdhar BK, Girdhar A, Chakma JK, Sengupta U. Lepr Rev; 2007 Dec; 78(4):386-90. PubMed ID: 18309713 [Abstract] [Full Text] [Related]
47. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients. Sampaio EP, Malta AM, Sarno EN, Kaplan G. Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):268-73. PubMed ID: 8862260 [Abstract] [Full Text] [Related]
48. A study of serum fibrinolytic activity in erythema nodosum leprosum (ENL). Jain VK, Verma KC, Aggarwal SS. Lepr India; 1983 Jan; 55(1):95-9. PubMed ID: 6876766 [Abstract] [Full Text] [Related]
52. Pattern of bacillary clearance in multibacillary leprosy patients with multidrug therapy. Kumar A, Girdhar A, Girdhar BK. Acta Leprol; 2003 Jun; 12(3):123-8. PubMed ID: 15040703 [Abstract] [Full Text] [Related]
53. Solubilization of preformed immune complexes in sera of patients with type 1 and type 2 lepra reactions. Chakrabarty AK, Kashyap A, Sehgal VN, Saha K. Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):559-65. PubMed ID: 3221112 [Abstract] [Full Text] [Related]
54. Methotrexate in resistant ENL. Kar BR, Babu R. Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):480-2. PubMed ID: 15755203 [Abstract] [Full Text] [Related]
57. Comparison of the efficacy and safety of minocycline and clofazimine in chronic and recurrent erythema nodosum leprosum-A randomized clinical trial. Hanumanthu V, Thakur V, Narang T, Dogra S. Dermatol Ther; 2021 Nov; 34(6):e15125. PubMed ID: 34490707 [Abstract] [Full Text] [Related]
58. Serum immunoglobulins an autoantibodies during and after erythema nodosum leprosum (ENL). Sharma VK, Saha K, Sehgal VN. Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):159-63. PubMed ID: 6811448 [Abstract] [Full Text] [Related]
59. A transient rise in agalactosyl IgG correlating with free interleukin 2 receptors, during episodes of erythema nodosum leprosum. Filley E, Andreoli A, Steele J, Waters M, Wagner D, Nelson D, Tung K, Rademacher T, Dwek R, Rook GA. Clin Exp Immunol; 1989 Jun; 76(3):343-7. PubMed ID: 2787714 [Abstract] [Full Text] [Related]